News

Latest

Gaelic Labs: Pharma is increasingly focused on supply chain security

2026-04-01T08:30:00+01:00By Dominic Tyer (European Pharmaceutical Review)

General Manager Brian Morrissey discuss his company’s acquisition of fellow Beta-Lactam manufacturer Athlone Laboratories and its implications for an evolving industry.

News
Framework supports microbiota assessment in cleanroom changing rooms
2026-03-30T11:33:00+01:00By Catherine Eckford (European Pharmaceutical Review)
News
Holistic automation for data integrity, usability and sustainability
2026-03-27T15:37:00+00:00Sponsored by IMA Pharma
News
Novo Nordisk’s Awiqli first FDA-approved once-weekly basal insulin
2026-03-27T12:19:00+00:00By Catherine Eckford (European Pharmaceutical Review)

Special reports

News
Johnson & Johnson’s Caplyta demonstrates phase III promise for depression
2026-01-19T13:18:00+00:00By Catherine Eckford (European Pharmaceutical Review)
Combination therapy comprising of an antidepressant and small molecule drug significantly boosted remission rates in adults with major depressive disorder.
News
Chemical assessment in Europe to be streamlined under new legislation
2026-01-08T11:24:00+00:00By Catherine Eckford (European Pharmaceutical Review)
The European Commission’s new framework aims to improve safety assessment of chemicals to better protect human health and the environment.
News
Endotoxin testing milestone reached with European Pharmacopoeia’s animal shift
2026-01-07T12:03:00+00:00By Catherine Eckford (European Pharmaceutical Review)
The quality control (QC) standards publication sets animal-free bacterial endotoxins testing (BET) as the new norm in Europe.
News
Impurities findings could enhance peptide drug safety
2025-12-09T16:10:00+00:00By Catherine Eckford (European Pharmaceutical Review)
EpiVax and Cubrc research supports FDA guidance on impurity risk assessment in generic peptides.

More special reports

Opinion

More opinion

All news articles

News

Merck expands haematology pipeline with $6.7bn acquisition of Terns Pharmaceuticals

2026-03-26T12:41:00+00:00By Catherine Eckford (European Pharmaceutical Review)

Deal strengthens Merck’s oncology portfolio with addition of a potential best-in-class oral TKI for chronic myeloid leukaemia.

News

UCB positions new Georgia biologics facility as future US manufacturing hub

2026-03-25T12:35:00+00:00By Catherine Eckford (European Pharmaceutical Review)

The biopharmaceutical company’s latest manufacturing venture represents one of the largest investments in Georgia’s history.

News

AstraZeneca’s Imfinzi wins EU-first immunotherapy approval in early GI cancers

2026-03-24T14:39:00+00:00By Catherine Eckford (European Pharmaceutical Review)

The approval represents the pharmaceutical company’s third perioperative approval in Europe for an Imfinzi-based regimen.

News

Gilead acquires potential first-in-class T cell engager in $2bn deal with Ouro Medicines

2026-03-24T12:29:00+00:00By Catherine Eckford (European Pharmaceutical Review)

T cell engager gamgertamig could redefine standard of care for immune-mediated diseases.

News

Nanoparticle-exosome innovation could enhance cell therapy manufacturing

2026-03-24T12:22:00+00:00By Catherine Eckford (European Pharmaceutical Review)

Novel, end-to-end process improves all four steps of exosome production simultaneously, supporting the design of more effective treatments.

News

BMS wins dual immunotherapy-first approvals in classical Hodgkin Lymphoma

2026-03-23T12:16:00+00:00By Catherine Eckford (European Pharmaceutical Review)

Expanded EU and US approvals for Bristol Myers Squibb’s Opdivo (nivolumab) position combination therapy as frontline option for the common blood cancer.

News

Novartis strengthens its breast cancer pipeline with $3bn Synnovation acquisition

2026-03-20T12:04:00+00:00By Catherine Eckford (European Pharmaceutical Review)

Deal to help address the significant unmet need in HR+/HER2- breast cancer and other advanced solid tumours.

News

Pennsylvania to house new actinium-225 manufacturing facility

2026-03-19T11:35:00+00:00By Catherine Eckford (European Pharmaceutical Review)

Construction of TerraPower Isotopes’ cGMP facility increases its production capacity for the rare isotope, helping to boost global access to targeted alpha therapies.

News

Sandoz partners with Samsung Bioepis to accelerate biosimilar pipeline

2026-03-18T10:34:00+00:00By Catherine Eckford (European Pharmaceutical Review)

New licensing, development and commercialisation agreement could expand Sandoz’s pipeline by to up to 32 assets.

News

Upcycled plastic could facilitate production of Parkinson’s drug

2026-03-17T09:40:42+00:00By Catherine Eckford (European Pharmaceutical Review)

Bioengineered E.coli provide an eco alternative to creating L-DOPA from terephthalic acid, suggests study.

News

Eli Lilly doubles down on supply chain investment in Asia

2026-03-16T13:19:00+00:00By Catherine Eckford (European Pharmaceutical Review)

Pharma giant to strengthen manufacturing capabilities in Japan and add capacity in China for its first oral GLP-1 therapy candidate, orforglipron.

News

Sana's islet cell transplant therapy shows early promise in type 1 diabetes

2026-03-16T11:37:11+00:00By Catherine Eckford (European Pharmaceutical Review)

Biotech company’s long-term data demonstrated hypoimmune (HIP)-modified islet transplantation without immunosuppression in type 1 diabetes.

News

Neuro-specialist Lundbeck hires new AI lead

2026-03-13T14:46:41+00:00By Catherine Eckford (European Pharmaceutical Review)

New recruit brings over 15 years of leadership experience to the brain health-focused biopharmaceutical company.

News

Chiesi and Bespak further collaboration to advance UK production of low carbon inhalers

2026-03-12T14:53:50+00:00By Catherine Eckford (European Pharmaceutical Review)

Partnership increases industrial scale of low carbon pressurised metered dose inhalers (pMDIs), accelerating pharma’s transition to a more sustainable option.